Skip to main content
Log in

Triptolide Inhibits Expression of Inflammatory Cytokines and Proliferation of Fibroblast-like Synoviocytes Induced by IL-6/sIL-6R-Mediated JAK2/STAT3 Signaling Pathway

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

Triptolide, a component of the Chinese herb Tripterygium wilfordii Hook F, has been proved to be effective in the treatment of rheumatoid arthritis (RA). However, its underlying mechanisms on RA have not yet been well established. We observed the inhibitory effect of triptolide on the expression of inflammatory cytokines and proliferation of fibroblast-like synoviocytes (FLS) induced by the complex of interleukin-6 (IL-6) and the soluble form of the IL-6 receptor (sIL-6R). Furthermore, to clarify the underlying mechanisms, we treated FLS with the Janus-activated kinase 2 (JAK2) inhibitor/signal transducer and activator of transcription 3 (STAT3) activation blocker AZD1480. In this study, immunohistochemical staining was used to identify vimentin (+) and CD68 (−) in FLS. The FLS proliferation was measured by cell proliferation assay, and the cell cycles were analyzed by flow cytometry. Furthermore, ELISA was used to detect the expression of the inflammatory factors in culture solution. The expression levels of p-JAK2, JAK2, p-STAT3 and STAT3 were investigated through Western blotting analysis. The results showed that IL-6/sIL-6R significantly increased the cell proliferation and expression of inflammatory cytokines, including IL-6, interleukin-1β (IL-1β) and vascular endothelial growth factor (VEGF). Triptolide or AZD1480 inhibited the cell proliferation and inflammatory cytokine expression in IL-6/sIL-6R-stimulated FLS by suppressing JAK2/STAT3. The study suggested that the physiological effects of triptolide on RA were due to its contribution to the inhibition of the inflammatory cytokine expression and FLS proliferation by suppressing the JAK2/STAT3 signaling pathway. It may provide an innovative insight into the effect of triptolide in preventing RA pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Niu HQ, Zhao WP, Zhao XC, et al. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway. Int Immunopharmacol, 2018,61:45–53

    Article  CAS  Google Scholar 

  2. Wu J, Qu Y, Zhang YP, et al. RHAMM induces progression of rheumatoid arthritis by enhancing the functions of fibroblast-like synoviocytes. BMC Musculoskelet Disord, 2018,19(1):455

    Article  CAS  Google Scholar 

  3. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev, 2010,233(1):233–255

    Article  CAS  Google Scholar 

  4. Chang SK, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev, 2010, 233(1):256–266

    Article  CAS  Google Scholar 

  5. MGA B, CEJ W, Wiegertjes R, et al. A three-dimensional model to study human synovial pathology. ALTEX, 2019,36(1):18–28

    Article  Google Scholar 

  6. Scheller J, Kovaleva M, Rabe B, et al. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition. J Immunol Methods, 2004,291(1–2):93–100

    Article  CAS  Google Scholar 

  7. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol, 2006,63(5):321–329

    Article  CAS  Google Scholar 

  8. Migita K, Koga T, Komori A, et al. Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium. J Rheumatol, 2011,38(11):2309–2317

    Article  CAS  Google Scholar 

  9. Yang Y, Ye Y, Qiu Q, et al. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway. Int Immunopharmacol, 2016,41:8–16

    Article  Google Scholar 

  10. Tao X, Fan F, Hoffmann V, et al. Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice. Arthritis Res Ther, 2006,8(1):R24

    Article  Google Scholar 

  11. Zhang L, Chang J, Zhao Y, et al. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Int J Nanomedicine, 2018,13:2051–2064

    Article  CAS  Google Scholar 

  12. Qian K, Zhang L, Shi K. Triptolide prevents osteoarthritis via inhibiting hsa-miR-20b. Inflammopharmacology, 2019,27(1):109–119

    Article  Google Scholar 

  13. Ritter JM. Drugs and the skin: psoriasis. Br J Clin Pharmacol, 2012,74(3):393–395

    Article  Google Scholar 

  14. Huber LC, Distler O, Tarner I, et al. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford), 2006,45(6):669–675

    Article  CAS  Google Scholar 

  15. Wen HL, Yang G, Dong QR. Ellipticine inhibits the proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via the STAT3 pathway. Immunopharmacol Immunotoxicol, 2017, 39(4):219–224

    Article  CAS  Google Scholar 

  16. Kusunoki N, Yamazaki R, Kitasato H, et al. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol, 2004,4:2

    Article  Google Scholar 

  17. Vernal R, Velásquez E, Gamonal J, et al. Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint. Arch Oral Biol, 2008,53(10): 910–915

    Article  CAS  Google Scholar 

  18. You S, Yoo SA, Choi S, et al. Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci USA, 2014,111(1):550–555

    Article  CAS  Google Scholar 

  19. Li Y, Xu JZ, Gu CX, et al. Carvacrol suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes. J Cell Biochem, 2018

  20. Biggioggero M, Crotti C, Becciolini A, et al. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. Drug Des Devel Ther, 2018,13:57–70

    Article  Google Scholar 

  21. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford), 2004,43(Suppl 3):iii2–2iii9

    Google Scholar 

  22. Kondo Y, Suzuki K, Inoue Y, et al. Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis. Arthritis Res Ther, 2019,21(1):14

    Article  Google Scholar 

  23. Gao W, Sweeney C, Walsh C, et al. Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2. Ann Rheum Dis, 2013,72(6):1080–1088

    Article  CAS  Google Scholar 

  24. Choe JY, Park KY, Park SH, et al. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. Arthritis Res Ther, 2013,15(1):R26

    Article  CAS  Google Scholar 

  25. Kim SK, Park KY, Yoon WC, et al. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis. Joint Bone Spine, 2011,78(5):471–477

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun Yang or Jian Weng.

Additional information

This study was supported by grants from the Shenzhen City Science and Technology Bureau of China (No. JCYJ20170307111755218) and “San-Ming” Project of Medicine in Shenzhen (No. SZSM201612092).

Conflict of Interest Statement

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Jj., Tao, K., Gao, N. et al. Triptolide Inhibits Expression of Inflammatory Cytokines and Proliferation of Fibroblast-like Synoviocytes Induced by IL-6/sIL-6R-Mediated JAK2/STAT3 Signaling Pathway. CURR MED SCI 41, 133–139 (2021). https://doi.org/10.1007/s11596-020-2302-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-020-2302-1

Key words

Navigation